Zentalis Pharmaceuticals, Inc. (ZNTL)

Last Closing Price: 1.34 (2025-06-13)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Zentalis Pharmaceuticals, Inc. (ZNTL) had Weighted-Average Shares Outstanding (Diluted) of 71.08M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$67.42M
$-165.84M
--
$67.42M
$258.62M
$-191.19M
$25.50M
$-165.69M
$-165.69M
$-165.87M
$-165.87M
$-165.87M
$-165.87M
$-191.19M
$-194.17M
71.08M
Weighted-Average Shares Outstanding (Diluted)
71.08M
$-2.33
$-2.33
Balance Sheet Financials
$386.07M
$4.70M
$44.27M
$430.34M
$52.73M
--
$40.43M
$93.15M
$337.19M
$337.19M
$337.19M
71.28M
Cash Flow Statement Financials
$-170.86M
$176.56M
$0.11M
$30.72M
$36.53M
$5.81M
$67.27M
--
--
Fundamental Metrics & Ratios
7.32
--
--
--
--
100.00%
-283.57%
-283.57%
-287.98%
-245.74%
-245.96%
$-171.02M
--
--
--
0.16
--
13.48
27.07
-49.19%
-49.19%
-38.54%
-49.19%
$4.73
$-2.41
$-2.40